IL6 and neoplasm: Quagliariello et al. [92] demonstrated that coadministration of rapamycin and QUE could reduce the levels of IL-8, IL-6, and IL-19, suggesting that such combinations could modulate the body's immune system and thus enhance the tumor-killing capability.